SM 10906

Known as: SM-10906 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2000
01219942000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
The present study investigated the effects of stable agonist for prostaglandin (PG) I2 receptor with PGI1 skeleton, SM-10906, on… (More)
Is this relevant?
1997
1997
The effects of prostaglandin (PG) I1 analog, SM-10906 (SM-6) and PGE1 on extracellular matrix formation and the release of… (More)
Is this relevant?
1997
1997
SM-10902 ((+)-methyl [2-[(2R,3aS,4R,5R,6aS)-octahydro-5-hydroxy-4-[(E)-(3S,5S)-3- hydroxy-5-methyl-1-nonenyl]-2-pentalenyl]ethoxy… (More)
Is this relevant?
1996
1996
Prostaglandins E1, prostaglandin E2, 3-oxa-methano-prostaglandin I1 (SM-10906), a stable prostaglandin I2 analog, and dibutyryl… (More)
Is this relevant?
1996
1996
The antithrombotic effect of topical application of the 3-oxa-methano-prostaglandin (PG) I1 analog, SM-10902 in the… (More)
Is this relevant?
1995
1995
The newly synthesized prostaglandin (PG) I1 analogues, SM-10902 and SM-10906, were compared with PGE1 in terms of their… (More)
  • figure 2
  • figure 4
  • table 1
  • figure 5
  • figure 8
Is this relevant?
1995
1995
The mechanism of the antiplatelet functions of SM-10906, the active form of the 3-oxa-methano-prostaglandin (PG) I1 analog SM… (More)
Is this relevant?
1994
1994
The prostacyclin I1 (PGI1) analogue, SM-10906 and its methyl ester, SM-10902, have been compared with the PGI2 analogue, iloprost… (More)
Is this relevant?
1994
1994
The pharmacological characteristics of the 3-oxamethano-prostaglandin I1 compound (+)-methyl [2-[(2R,3aS,4R,5R,6aS)-octahydro-5… (More)
Is this relevant?